Kestra Medical Technologies (NASDAQ:KMTS) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Kestra Medical Technologies (NASDAQ:KMTS) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Kestra Medical Technologies (NASDAQ:KMTS) was given a new $30.00 price target on by analysts at Stifel Nicolaus.
Kestra Medical Technologies (NASDAQ:KMTS) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Kestra Medical Technologies (NASDAQ:KMTS) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.